Page last updated: 2024-08-24

halofuginone and Lung Neoplasms

halofuginone has been researched along with Lung Neoplasms in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Baird, L; Miyata, K; Naito, M; Panda, H; Saito, R; Suzuki, M; Uruno, A; Wen, H; Yamamoto, M1
Ceylan, H; Demiroglu-Zergeroglu, A; Donbaloglu, F; Karadeniz Cerit, K; Odongo, RR; Topal, H; Turhal, G1
Amiaud, J; Brion, R; Heymann, D; Lamora, A; Mullard, M; Redini, F; Verrecchia, F1
Chen, Y; Gong, L; Hou, H; Ji, K; Liu, N; Liu, W; Wang, P; Wang, Y; Zhao, L1
Bièche, I; Blanc, JF; Dugot-Senant, N; Laurendeau, I; Pines, M; Rosenbaum, J; Rullier, A; Taras, D1

Other Studies

5 other study(ies) available for halofuginone and Lung Neoplasms

ArticleYear
Halofuginone micelle nanoparticles eradicate Nrf2-activated lung adenocarcinoma without systemic toxicity.
    Free radical biology & medicine, 2022, Volume: 187

    Topics: Adenocarcinoma of Lung; Chromatography, Liquid; Humans; Kelch-Like ECH-Associated Protein 1; Lung Neoplasms; Micelles; Nanoparticles; NF-E2-Related Factor 2; Oxidative Stress; Piperidines; Quinazolinones; Tandem Mass Spectrometry

2022
Anticarcinogenic effects of halofuginone on lung-derived cancer cells.
    Cell biology international, 2020, Volume: 44, Issue:9

    Topics: Anticarcinogenic Agents; Apoptosis; bcl-2-Associated X Protein; Carcinoma, Non-Small-Cell Lung; Caspase 3; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Humans; Lung; Lung Neoplasms; MAP Kinase Signaling System; Mesothelioma, Malignant; p38 Mitogen-Activated Protein Kinases; Piperidines; Proto-Oncogene Proteins c-bcl-2; Quinazolinones; Signal Transduction; STAT3 Transcription Factor

2020
Anticancer activity of halofuginone in a preclinical model of osteosarcoma: inhibition of tumor growth and lung metastases.
    Oncotarget, 2015, Jun-10, Volume: 6, Issue:16

    Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Bone Remodeling; Cell Line, Tumor; Cell Proliferation; Disease Progression; Female; Humans; Lung Neoplasms; Mice; Mice, Nude; Neoplasm Metastasis; Osteosarcoma; Piperidines; Quinazolinones; Signal Transduction; Transfection

2015
Halofuginone inhibits radiotherapy-induced epithelial-mesenchymal transition in lung cancer.
    Oncotarget, 2016, Nov-01, Volume: 7, Issue:44

    Topics: Animals; Antineoplastic Agents; Benzamides; Carcinoma, Lewis Lung; Cell Movement; Dioxoles; Epithelial-Mesenchymal Transition; Female; Lung Neoplasms; Mice; Mice, Inbred C57BL; Neoplasm Invasiveness; Piperidines; Quinazolinones; Smad Proteins; Transforming Growth Factor beta1; Xenograft Model Antitumor Assays

2016
Halofuginone suppresses the lung metastasis of chemically induced hepatocellular carcinoma in rats through MMP inhibition.
    Neoplasia (New York, N.Y.), 2006, Volume: 8, Issue:4

    Topics: Angiogenesis Inhibitors; Animals; Carcinoma, Hepatocellular; Liver Neoplasms; Lung Neoplasms; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Matrix Metalloproteinases, Membrane-Associated; Neoplasm Metastasis; Piperidines; Quinazolines; Quinazolinones; Rats; Rats, Inbred F344

2006